FDA fast track

Cons Outweigh Potential Pros to BPC Plan on Stem Cells & FDA

BPC-report-stem-cels

There is considerable interest in FDA regulatory reform here in the U.S. for stem cell therapies. The goal is to get new treatments to patients faster, but is there a way to do that without sacrificing proven safety and efficacy? You need convincing data on both safety and efficacy or speed becomes dangerous. A group called …

Cons Outweigh Potential Pros to BPC Plan on Stem Cells & FDA Read More »

Key questions for stem cell field bouncing around on a Friday morning

ViaCyte-New-Logo

What are the most interesting questions for the stem cell field in 2014 right now? What’s on your mind? I’m not going to give this deep thought, but rather just list those questions bouncing around at the moment in no particular order. You can see a lot of translational/clinical things are on my mind. I’ve …

Key questions for stem cell field bouncing around on a Friday morning Read More »